Zobrazeno 1 - 10
of 65
pro vyhledávání: ''
Autor:
Sumiyo Okawa, Takahiro Tabuchi, Kayo Nakata, Toshitaka Morishima, Shihoko Koyama, Satomi Odani, Isao Miyashiro
Publikováno v:
Cancer Science. 113:1047-1056
In Japan, cancer care hospitals designated by the national government have a surgical volume requirement of 400 annually, which is not necessarily defined based on patient outcomes. This study aimed to estimate surgical volume thresholds that ensure
Autor:
Akiyuki Wakita, Hiromu Fujita, Akira Anbai, Eri Maeda, Takahiro Higashi, Yoshihiro Minamiya, Yushi Nagaki, Katsunori Iijima, Yusuke Sato, Satoru Motoyama
Publikováno v:
Cancer Science
To address the major issue of regional disparity in the treatment for elderly cancer patients in an aging society, we compared the treatment strategies used for elderly patients with thoracic esophageal cancer and their survival outcomes in metropoli
Autor:
Yoichi Nakanishi, Yuichiro Ohe, Akihiko Gemma, Kazuhiko Nakagawa, Ayumi Akamatsu, Takahiko Sakamoto, Nobuyuki Yamamoto
Publikováno v:
Cancer Science
Postmarketing surveillance of Japanese patients with unresectable, previously treated, advanced or recurrent non‐small‐cell lung cancer treated with nivolumab was undertaken during the conditional approval period. The study aim was to evaluate th
Autor:
Tomoki Taki, Yoshie Murakami, Satoko Imai, Aoi Ebata, Masashi Akiyama, Honami Akanabe, Toru Urata, Shoichiro Mori, Kenji Yokota, Mao Okumura
Publikováno v:
Cancer Science
Angiosarcoma of the head and neck (ASHN) is one of the most aggressive malignancies of the skin, but the prognostic factors are not well known because of its rarity. Recently, high plasma fibrinogen levels were reported to predict poor prognosis in s
Autor:
Ono Takashi, Yuka Isozaki, Hiraku Sato, Yuma Iwai, Akihiro Nomoto, Hitoshi Ishikawa, Kenji Nemoto, Naoyoshi Yamamoto, Tomohiko Ichikawa, Hiroshi Tsuji, Goro Kasuya, Mio Nakajima
Publikováno v:
Cancer Science
There are no clinical reports of long‐term follow‐up after carbon‐ion radiotherapy (CIRT) using a dose of 51.6 Gy (relative biological effectiveness [RBE]) in 12 fractions for localized prostate cancer, or of a comparison of clinical outcomes b
Autor:
Satomi Odani, Takahiro Tabuchi, Shihoko Koyama, Toshitaka Morishima, Kayo Nakata, Isao Miyashiro, Sumiyo Okawa
Publikováno v:
Cancer Science
The Japanese national and prefectural governments have accredited high‐capacity, high‐experience cancer care hospitals as “designated cancer care hospitals” to standardize cancer care, centralize patients, and improve clinical outcomes, but t
Autor:
Miki Nagatsuka, Seiichiro Masui, Miwako K. Homma, Yuichiro Kiko, Yoshimi Homma, Naoto Katagata, Yuko Hashimoto, Tadashi Nomizu
Publikováno v:
Cancer Science
Overexpression of the ubiquitous protein kinase, CK2α, has been reported in various human cancers. Here, we demonstrate that nuclear and nucleolar CK2α localization in invasive ductal carcinomas of the breast is a reliable predictor of poor prognos
Autor:
Kunihiro Tsukasaki, Kisato Nosaka, Junji Tanaka, Kenji Ishitsuka, Kaoru Uchimaru, Yoshitaka Imaizumi, for collaborative Investigators, Masako Iwanaga, Masahiro Amano, Toshiki Watanabe, Kenichi Ishizawa, Koichi Ohshima, Naokuni Uike, Atae Utsunomiya, Yoshiki Tokura, Kensei Tobinai, Takashi Ishida, Shigeki Ito
Publikováno v:
Cancer Science
Adult T‐cell leukemia/lymphoma (ATL) is a mature T‐cell neoplasm and is classified into four subtypes (acute, lymphoma, chronic, and smoldering) according to the Shimoyama classification, established in 1991 through several nationwide surveys bas
Autor:
Ken Kato, Hirofumi Yasui, Satoru Iwasa, Takashi Ura, Keiko Minashi, Yuko Kitagawa, Atsushi Ohtsu, Yasuo Hamamoto, Takashi Kojima, Toshihiro Kudo, Hiroki Hara, Yuichiro Doki, Kensei Yamaguchi, Kei Muro, Takahiro Tsushima, Shuichi Hironaka
Publikováno v:
Cancer Science
The long‐term efficacy of nivolumab in esophageal squamous cell carcinoma and its association with disease biomarkers are currently not well known. Therefore, we investigated the association in Japanese patients with treatment‐refractory advanced
Autor:
Tomoko Sonoda, Kazuhiro Ogi, Tadashi Hasegawa, Shota Shimizu, Takanori Sasaki, Tomohide Tsukahara, Hiroyoshi Hiratsuka, Kei Tsuchihashi, Akihiro Miyazaki, Kazushige Koike, Takashi Sasaya, Jun-ichi Kobayashi, Toshihiko Torigoe, Koyo Nishiyama, Hironari Dehari
Publikováno v:
Cancer Science
Human leukocyte antigen (HLA) class Ⅰ molecules play a central role in anticancer immunity, but their prognostic value in oral squamous cell carcinoma (OSCC) remains unclear. We examined HLA class I expression in 2 distinct tumor compartments, name